Therefore, we believe that a deep discernment of p300 function in inflammation and oxidative stress, the two main drivers of diabetes-related endothelial dysfunction, is urgently needed to support new pre-clinical and clinical studies. This evidence concerns the gene EP300 and diabetes mellitus.